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Abstract In the last decade, the number and diversity of
nosocomial Candida infections has increased significantly,
resulting in an emergent need for rapid and accurate
methods for Candida identification. Therefore, the aim of
this study was to evaluate the performance of three
biochemical systems (Auxacolor, ID32C, and Vitek 2
YST) for the identification of Candida species, comparing
them with molecular identification (polymerase chain
reaction and gel agarose electrophoresis). These methods
were used to assess Candida spp. (229 clinical isolates)
prevalence and distribution among clinical specimens. The
biochemical methods with higher percentages of correct
identification were Vitek 2 YST (79.6%) and Auxacolor
(78.6%). However, overall the biochemical methods
assayed differed from the molecular identification. Thus,
due to their rapid and precise identification, molecular
methods are promising techniques for Candida species
identification in clinical laboratories. Candida albicans and
Non Candida albicans Candida species had a similar
prevalence (50.4 and 49.6%, respectively), corroborating
the epidemiological shift observed for these pathogens in
the recent years.
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Introduction
In the last two decades, the incidence of Candida infections,
associated with high morbidity and mortality (Goodrich et al.
1991; Beck-Sagué and Jarvis 1993; Karlowsky et al. 1997;
Nucci et al. 1997), has increased remarkably (Warren and
Hazen 1995; Wingard 1995; Ribeiro et al. 2004). Although
Candida albicans is the most prevalent species (Fridkin and
Jarvis 1996), an epidemiological shift of Candida pathogens
has been recently denoted by the increasing number of
infections caused by non-Candida albicans Candida
(NCAC) species (Hazen 1995; Jarvis 1995; Fridkin and
Jarvis 1996; Nauyen et al. 1996). This increased species
diversity and incidence of infections resulted in the need for
rapid and accurate methods for Candida identification
(Verweij et al. 1999; Wadlin et al. 1999; Hsu et al. 2003;
Crocco et al. 2004). This will have a decisive contribution in
the evolution of treatment by adequate antifungal selection,
and allow the epidemiologic study of colonization and
infection in hospitals (Campbell et al. 1999; Verweij et al.
1999; Ribeiro et al. 2004). Several commercial systems have
been developed and compared for yeast identification (Fenn
et al. 1994; Gutierrez et al. 1994; Fricker-Hidalgo et al. 1995;
Verweij et al. 1999; Hata et al. 2007), such as the manual
Auxacolor (colorimetric) and ID32C (turbidimetric) systems,
and the automated Vitek 2 YST (colorimetric) system
(Campbell et al. 1999; Verweij et al. 1999). Table 1 shows
a brief review of the comparison of the methods found in the
literature.
Misidentifications between some Candida species are
frequently observed, particularly between C. dubliniensis
and C. albicans (Abaci et al. 2008). To distinguish between
them, methods such as the latex agglutination test can be
used (Kurzai et al. 1999; Marot-Leblond et al. 2006).
However, in spite of the advances in biochemical commer-
cial systems, so far they do not allow for the rapid diagnosis of
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invasive fungal infections (Goodwin et al. 1992; Hazen 1995;
Espinel-Ingroff et al. 1998), leading to a late introduction of
the specific antifungal therapy (Goodwin et al. 1992; Hazen
1995; Espinel-Ingroff et al. 1998; Hsu et al. 2003; Huang et
al. 2006). In this sense, molecular biology techniques, such
as PCR, might be more accurate and efficient, due to their
reproducibility, high specificity, and sensitivity (Hidalgo et
al. 2000; Kanbe et al. 2002, 2003; Hsu et al. 2003), allowing
same day identification. Nevertheless, their lack of standard-
ization for Candida species identification, as well as the
extra costs associated and the reliance on Candida cultures
that results in a considerable delay in comparison to direct
specimen detection, may limit its use.
The aim of this study, carried out at the Service of
Clinical Pathology of Hospital de São Marcos (HSM), was
to evaluate the performance of the biochemical systems
Auxacolor, ID32C, and Vitek 2 YST for the identification
of Candida species, comparing to a molecular identifica-
tion, and to assess Candida spp. prevalence and distribution
among clinical specimens.
Materials and methods
Clinical isolates and culture conditions A total of 229
isolates were randomly isolated from clinical samples
(sputum/bronchial wash/bronchoalveolar lavage, vaginal
swab, blood culture, catheter tip and urine, among others)
between December 2005 and March 2007, in HSM. The
clinical isolates were kept in Brain Heart Infusion (BHI,
37 g/l; Bio-Rad, Marnes-la-Coquette, France) with 10%
glycerol (Vaz Pereira, Lisbon, Portugal), at -70°C. Prior to
testing, isolates were retrieved from storage and subcul-
tured, for 24 to 48 h, on plates of Columbia sheep blood
agar (bioMérieux, Lyon, France).
Reference strains For quality control, ATCC strains were
used: Candida albicans ATCC 90028, C. albicans ATCC
14053, Candida glabrata ATCC 2001, Candida tropicalis
ATCC 750, Candida parapsilosis ATCC 22019 and
Candida krusei ATCC 6258 (MicroBiologics, Saint Cloud,
MN, USA); and a Candida dubliniensis strain provided by
Biognóstica from United Kingdom National External
Quality Assessment Service. These strains were maintained
and grown as described for clinical isolates.
Biochemical identification
Auxacolor system The yeast identification procedures were
performed according to the manufacturer’s instructions
(Bio-Rad). The results were read after incubation for 24 h
Table 1 Brief review of method comparisons in the literature
Authors Year Compared methods Conclusions
Fenn et al. 1994 Vitek Yeast Biochemical Card (YBC); API
20C
Vitek YBC compared favourably with the API 20C in the
identification of common yeasts.
However, Vitek demonstrated problems in the identification of
C. tropicalis, C. krusei, Trichosporon spp., and some
Cryptococcus spp.
Fricker-Hidalgo et al. 1995 Auxacolor; ID 32C Auxacolor was found to be reliable when performed in
conjunction with morphological tests. Furthermore, Auxacolor
provided faster results than ID 32C.
Verweij et al. 1999 Vitek; ID 32C; Api 20C AUX; Yeast Star;
Auxacolor; RapID Yeast Plus system; Api
Candida; Conventional tests
Auxacolor and Api Candida appeared to be the most useful
systems for identification of germ tube negative yeasts.
Wadlin et al. 1999 RapID Yeast Plus System; API 20C Aux;
Vitek Yeast Biochemical Card, microscopic
morphologic reference method
The RapID Yeast Plus System was significantly better than the
other methods.
There was no significant difference between results obtained
with API 20C Aux and Vitek Yeast Biochemical Card.
Campbell et al. 1999 API Candida; Auxacolor The methods had similar percentages of correct identification.
However, the API Candida system required supplemental
biochemical tests or morphological assessment to obtain the
correct identification, and gave more incorrect identifications.
Kanbe T et al. 2003 PCR amplification; Conventional
identification techniques
The results of identification of clinical samples based on the
PCR amplification coincided with those of conventional
identification techniques.
Liguori et al. 2007 Multiplex PCR assay; Routine phenotypic
culture identification
The multiplex PCR assay provides a rapid alternative to the
conventional culture based technique for the identification and
speciation of the most frequently isolated Candida species.
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and 48 h, and identifications were made by referring to the
list of numerical profiles provided by the manufacturer.
ID32C system All tests were performed according to the
manufacturer’s instructions (bioMérieux). The results were
read automatically after incubation for 24 and 48 h using
the mini API system (bioMérieux).
Vitek 2 YST system The yeast identification procedures were
performed according to the manufacturer’s instructions
(bioMérieux). Cards were automatically read, and after
approximately 18 h a final identification was obtained using
the Vitek 2 database.
Latex aglutination test Bichro-Dubli Fumouze latex agglu-
tination test (Fumouze Diagnostics, Levallois-Perret Cedex,
France) was performed to identify C. dubliniensis strains.
This test is based on the coagglutination of C. dubliniensis
blastoconidia with blue latex particles coated with a
monoclonal antibody, allowing the specific detection of
the C. dubliniensis cell-surface antigen. All tests were
performed according to the manufacturer’s instructions.
Molecular identification
DNA purification A 100 μl yeast suspension was prepared
in aqueous saline solution 0.45% (w/v) NaCl with a
turbidity equivalent to 2.0 McFarland. DNA was extracted,
isolated and purified according to the protocol of Magna
Pure LC DNA Isolation Kit III (Roche Applied Science,
Amadora, Portugal). Purified DNAwas preserved at −20°C.
Nested PCR DNA samples were amplified in a reaction
mixture (50 μl) that contained 5 μl genomic DNA, 17 μl
double distilled water (ddH2O; Roche Applied Science),
1.5 μl of each degenerated primer (Table 2) targeting
Candida DNA topoisomerase II gene, which were chosen
Table 2 Primers used for PCR amplification, oligonuclotide sequences and fragment size
Primer and target species Name Sequence (5′–3′) Amplified fragment size (bp)
Degenerated primers CDF28 GGTGGWMGDAAYGGDTWYGGYGC 1200
CDR148 CCRTCNTGATCYTGATCBGYCAT
Specific primers
Candida albicans CABF59 TTGAACATCTCCAGTTTCAAAGGT 515
CABR110 GTTGGCGTTGGCAATAGCTCTG 665
CADBR125 AGCTAAATTCATAGCAGAAAGC
Candida dubliniensis CDBF28 AAATGGGTTTGGTGCCAAATTA 816
CDBR110 GTTGGCATTGGCAATAGCTCTA 966
CADBR125 AGCTAAATTCATAGCAGAAAGC
Candida tropicalis I CTPIF36 GTTGTACAAGCAGACATGGACTG 318
CTPIR68 CAAGGTGCCGTCTTCGGCTAAT 853
CTPIR121 TCAAGGTACAGTTATGGCCAAGTT
Candida tropicalis II* CTPIIF36 CTGGGAAATTATATAAGCAAGTT 246
CTPII60 CTTGAGATACTCAATCTTTTATC 860
CTPIIR121 TCAATGTACAATTATGACCGAGTT
Candida parapsilosis I CPPIF41 TGACAATATGACAAAGGTTGGTA 228
CPPIR61 ACTTTTAAAACTGTTAACCGA 837
CPPIR122 TGTCAAGATCAACGTACATTTAGT
Candida parapsilosis IIa CPPIIF41 GGACAACATGACAAAAGTCGGCA 310
CPPIIR69 TTGTGGTGTAATTCTTGGGAG 837
CPPIIR122 GGTAAGGATCAAAGTGCACTTTA
Candida krusei CKSF35 GAGCCACGGTAAAGAATACACA 227
CKSR57 TTTAAAGTGACCCGGATACC 756
CKSR110 TTTCTCTGGCAATTCCAATCG
Candida glabrata CGBF35 CCCAAAAATGGCCGTAAGTATG 419
CGBR77 CTGCTTGAAAGAAATATCGGAGAC 674
CGBR103 ATAGTCGCTACTAATATCACACC
a These species have two distinct genotypes in the DNA topoisomerase gene12
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according to Kanbe et al. (2002), and 25 μl PCR Master
Mix (Roche Applied Science). The PCR was performed in
a thermocycler (T1 Model; Biometra, Goettingen, Ger-
many) with the following cycle parameters: preheating at
94°C for 2 min, 40 cycles at 94°C for 30 s, 55°C for 20 s,
and 72°C for 90 s. These PCR products were further
amplified by species specific primers (Table 2), also
targeting Candida DNA topoisomerase II gene (Kanbe et
al. 2002), in a reaction mixture containing 19.5 μl ddH2O,
1.5 μl of each species specific primers, 25 μl PCR Master
Mix, and 1 μl DNA template. The PCR thermocycler
parameters were the same as described above.
Agarose gel electrophoresis Detection of PCR products
was performed by electrophoresis (MiniRun GE-100;
Bioer, Tokyo, Japan) on a 1.2% agarose (QA-Agarose
TM; MP Biomedicals, Illkirch, France) gel prepared in
0.5X Tris-Borate-EDTA (TBE; Severn Biotech, Worcester-
shire, UK), at 100 V for 35 min in TBE. Gels were stained
with ethidium bromide (10 mg/ml; Molecular Sigma
Biology, Sintra, Portugal) for 20 min, and destained in
TBE for 10 min. DNA bands were visualized with a UV
transilluminator (Model TM-15E Chromato-Vue®; UVP,
Cambridge, UK) and photographed. PCR product band size
was determined by comparison with a 100 bp DNA ladder
(Zymo Research, Orange, CA, USA) ran in the same gel.
Methodology for the analysis of the identification
results The biochemical systems of identification were
evaluated by comparison with the molecular method
(assumed as the reference). Since only the specific primers
for C. albicans, C. parapsilosis, C. tropicalis, C. glabrata,
C. krusei, and C. dubliniensis were acquired, just 196
isolates were compared. Biochemical identification was
understood as: correct when identical to the molecular
results; incomplete when it gave more than one possibility
of identification (including the correct); incorrect when
different from the molecular results; and unidentified when
the test gave no identification at all.
Statistical analysis Data from Candida species identifica-
tion were statistically analyzed with Statistical Package for
Social Sciences (SPSS), using the Cochran’s Q and
McNemar tests with a confidence level of 95%.
Results
Biochemical and molecular identification
Table 3 summarizes the identification results obtained by
the biochemical methods for Candida species, in compar-
ison with the molecular identification. The reference strains
were correctly identified by all methods, except for C.
glabrata 2001 and C. krusei 6258 with Auxacolor and C.
krusei 6258 with Vitek 2 YST, where incomplete identi-
fications were achieved. For the clinical isolates, C. para-
psilosis strains were the species most correctly identified by
the biochemical methods, while C. glabrata and C. krusei
were the species with lower levels of correct identification.
Overall, Vitek 2 YST and Auxacolor (48 h incubation)
gave the higher percentages of correct identification (79.6
and 78.6%, respectively).
Results of the biochemical and molecular identification
were firstly statistically analyzed with the Cochran’s Q test.
As the significance value (P=0.000) indicated significant
differences among the methods, their responses were
subsequently analyzed with the McNemar test. It was
possible to verify that ID32C results diverged significantly
from the other biochemical methods, being the method with
worst results for Candida species identification. Further-
more, it was observed that the incubation time is an
important aspect for the Auxacolor method, where signif-
icantly better results are achieved after 48 h incubation.
Results from biochemical methods were also compared
with molecular identification, as shown in Table 4. All the
biochemical methods provided significantly divergent
results from molecular identification, with the exception
of Auxacolor (48 h incubation) and ID32C (24 h incuba-
tion) for C. parapsilosis.
Latex agglutination test
The agglutination test, performed for strains identified as
C. albicans or C. dubliniensis by biochemical methods,
provided a positive result for one strain, identified as
C. dubliniensis by molecular methods, indicating its
accuracy.
Prevalence and distribution of Candida species
Figure 1 shows the prevalence and distribution of Candida
species among clinical specimens. Candida albicans was
the most prevalent species (50.4%), followed by C. para-
psilosis (13.9%), C. tropicalis (10.5%), C. glabrata (9.1%),
C. krusei (0.9%), C. dubliniensis (0.4%) and other
unidentified Candida species (14.8%). Candida species
were more frequently isolated from clinical specimens of
urine (38.9%), sputum/bronchial wash/bronchoalveolar la-
vage (24.9%), and vaginal swabs (11.4%). The second was
also the specimen where a major diversity of species was
encountered. Indeed, the only strain of C. dubliniensis and
the two strains of C. krusei identified were isolated from
sputum/bronchial wash/bronchoalveolar lavage. It should
also be noted that C. glabrata was isolated in higher
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Table 3 Results of the evaluation of 196 strains using the Auxacolor, ID 32C, and Vitek 2 YST systems, assuming the molecular method as
reference
Species System and ncubation time (h) Isolates with the following identification (%)
Correct Incomplete Incorrect Unidentified
Candida albicans (n=116) Auxacolor
24 82.8 0.9 2.6 13.8
48 92.2 0.9 2.6 4.3
ID32C
24 68.1 0.9 0.9 30.2
48 69.0 1.7 0.0 29.3
Vitek 2 YST 87.1 7.8 3.4 1.7
Candida parapsilosis (n=32) Auxacolor
24 62.5 9.4 21.9 6.3
48 93.8 3.1 0.0 3.1
ID32C
24 84.4 0.0 0.0 15.6
48 75.0 0.0 0.0 25.0
Vitek 2 YST 78.1 15.6 3.1 3.1
Candida tropicalis (n=24) Auxacolor
24 58.3 4.2 12.5 25
48 58.3 4.2 8.3 29.2
ID32C
24 50.0 8.3 4.2 37.5
48 66.7 0.0 4.2 29.2
Vitek 2 YST 75.0 0.0 4.2 20.8
Candida glabrata (n=21) Auxacolor
24 4.8 90.5 4.8 0.0
48 9.5 76.2 4.8 9.5
ID32C
24 42.9 0.0 0.0 57.1
48 52.4 0.0 0.0 47.6
Vitek 2 YST 52.4 14.3 4.8 28.6
Candida krusei (n=2) Auxacolor
24 0.0 100 0.0 0.0
48 0.0 100 0.0 0.0
ID32C
24 0.0 100 0.0 0.0
48 0.0 100 0.0 0.0
Vitek 2 YST 0.0 50.0 0.0 50.0
Candida dubliniensis (n=1) Auxacolor
24 100 0.0 0.0 0.0
48 100 0.0 0.0 0.0
ID32C
24 0.0 0.0 100 0.0
48 0.0 0.0 100 0.0
Vitek 2 YST 100 0.0 0.0 0.0
Candida (total) (n=196) Auxacolor
24 67.3 13.3 7.1 12.2
48 78.6 10.7 3.1 7.7
ID32C
24 64.8 2.6 1.5 31.1
48 66.8 2.0 1.0 30.1
Vitek 2 YST 79.6 9.2 3.6 7.7
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numbers from vaginal swabs, and C. parapsilosis from the
group identified as “Other”.
Discussion
In this work, three biochemical systems were evaluated
(Auxacolor, ID32C, and Vitek 2 YST) in comparison to
molecular identification. Considerable differences were
noted between the biochemical and molecular identifica-
tion, especially for ID32C, which was demonstrated to be
the less accurate system. These divergences were observed
for all Candida species, with the exception of C. para-
psilosis for Auxacolor (48 h incubation) and ID32C (24 h
incubation). Indeed, this species was the easiest to identify
by biochemical methods, followed by C. albicans, whose
levels of correct identification were high for Auxacolor and
Vitek 2 YST. On the other hand, C. glabrata and C. krusei,
usually associated with high levels of antifungal resistance,
posed the greatest identification problems. For C. krusei it
is not possible to reach any conclusion since the number of
isolates was too low (two). As for C. glabrata, it could be
said that it is the hardest species to identify, especially by
Auxacolor whose higher percentages of incomplete identi-
fication should be emphasized. Candida tropicalis, al-
though not with the extension of C. glabrata, was also
difficult to identify with ID32C and Auxacolor.
Regarding C. dubliniensis, since the number of strains
identified (one) did not allow a statistical analysis of its
identification, it can merely be stated that Vitek 2 YST and
Auxacolor correctly identified the isolate, and ID32C
identified it, incorrectly, as C. albicans. Indeed, the
distinction between these two species is problematic.
Therefore, a latex agglutination test was performed, which
Table 4 Significance values (P) obtained from the comparison between the results of biochemical systems and the molecular method
System and incubation time Significance (P)
Candida albicans Candida parapsilosis Candida tropicalis Candida glabrata Candida (overall)
Auxacolor 24 h 0.000 0.000 0.002 0.000 0.000
Auxacolor 48 h 0.004 0.500 0.002 0.000 0.000
ID32C 24 h 0.000 0.063 0.000 0.000 0.000
ID32C 48 h 0.000 0.008 0.008 0.002 0.000
Vitek 2 YST 0.000 0.016 0.031 0.002 0.000
Fig. 1 Distribution of Candida
species among clinical
specimens
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correctly identified the C. dubliniensis isolate. These results
agree with previous studies (Marot-Leblond et al. 2006;
Sahand et al. 2006) and indicate the accuracy of this test for
discrimination between C. dubliniensis and C. albicans.
It should be noted that the levels of correct identifi-
cation obtained in this study for the biochemical methods
were lower than reported in previous studies (Loïez et al.
2006; Hata et al. 2007; Sheppard et al. 1998). This may be
due, contrary to other studies, to the absence of supple-
mentary tests, which are very time consuming and
therefore disagree with the aim of this work that consisted
in finding an expeditious methodology for Candida
species identification.
In this work, we also compared the 24 and 48 h
incubation times for Auxacolor and ID32C. Significant
differences were found only for Auxacolor, showing better
identification results for a 48 h incubation, which is in
accordance with a previous study (Loïez et al. 2006).
In the present work, the prevalence and distribution of
Candida species among clinical specimens was, for the first
time, evaluated in HSM. The results obtained are in
accordance with previous studies (Krcmery and Barnes
2002; Fleck et al. 2007), with C. albicans being the most
prevalent species. However, NCAC levels are similar,
corroborating the values in literature that denote the
epidemiological shift of Candida pathogens perceived in
the last years (Hazen 1995; Jarvis 1995).
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